Results 161 to 170 of about 9,527 (221)

Febuxostat Loaded Microballoons: A Novel Approach for Gastric Retention

, 2021
Mohanlal Gupta, Umang Varia, Hitesh Katariya, Krunal Detholia   +3 more
openalex   +1 more source

Efficacy and Safety of Dotinurad Versus Febuxostat for the Treatment of Gout: A Randomized, Multicenter, Double-Blind, Phase 3 Trial in China. [PDF]

Arthritis Rheumatol
Sun J, Wang Y, Cheng Y, Guo D, Hu J, Liu D, Gao Z, Li C, Lu Y, Kong X, Liu Y, Jiang Z, Yi B, Zhang H, Xu B, Yu S, Kokan R, Ishikawa K, Kawakatsu M, Zhang Z.   +19 more
europepmc   +1 more source

Network pharmacology combined with ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry method to explore the mechanism of Shizhi Fang in treating uric acid nephropathy mice. [PDF]

J Tradit Chin Med
Feng Y, Xuming Z, Zhiyuan WU, Jiandong G.   +3 more
europepmc   +1 more source

Relationship between uric acid and blood pressure in different age groups [PDF]

, 2015

core   +1 more source

Effects of Xanthine Oxidase Inhibition by Febuxostat on Lipid Profiles of Patients with Hyperuricemia: Insights from Randomized PRIZE Study

Yuichi Saito, Atsushi Tanaka, Hisako Yoshida, Hitoshi Nakashima, Noriko Ban, Munehide Matsuhisa, Yoshio Kobayashi, Koichi Node, on behalf of the PRIZE Study Investigators   +8 more
openalex   +1 more source

Bioequivalence evaluation of generic febuxostat versus Feburic^® in healthy Chinese subjects: a randomized crossover study. [PDF]

BMC Pharmacol Toxicol
Wang F, Ye X, Li F, Kong H, Liao M, Kan M, Zhuang J, Wang A, Meng X.   +8 more
europepmc   +1 more source

Exploring the role of febuxostat's drug target XOR in erectile dysfunction: insights from human genetics and rat models. [PDF]

Front Med (Lausanne)
Chen Z, Li Y, Meng C, Li X, Liao H, Li X, Zeng Y, Li X, Zhou T, Deng Q.   +9 more
europepmc   +1 more source

Switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, may substantially reduce serum urate levels, through URAT1 inhibition, potentially without adversely affecting ABCG2 function: findings from the SWITCH SURI study. [PDF]

Front Endocrinol (Lausanne)
Osonoi T, Shirabe S, Saito M, Hosoya M, Watahiki N, Douguchi S, Ofuchi K, Katoh M.   +7 more
europepmc   +1 more source

Dual-drug nanocarriers for gout therapy: targeted co-delivery of anti-inflammatory and urate-lowering agents: a review. [PDF]

EXCLI J
Karusan NR, Tajuddin HA, Mat Radi NA, Karimah R, Soesilawati P, Mahmood S, Ahmad N.   +6 more
europepmc   +1 more source

The efficacy and safety of different doses of febuxostat and allopurinol: A meta-analysis. [PDF]

Jt Dis Relat Surg
Zhang F, Wang Y.
europepmc   +1 more source